Nicaragua ex-president Chamorro laid to rest in Costa Rica
SAN JOSÉ: Former Nicaraguan president Violeta Chamorro, who brought peace to the Central American country after years of war, was laid to rest Monday in Costa Rica two days after her death at age 95.
The first woman president of the Americas, who defeated ex-guerrilla leader and current president Daniel Ortega in 1990 elections, died in exile in neighboring Costa Rica.
Addressing her funeral mass in San Jose, her son Carlos Fernando Chamorro said he would take her ashes home to Nicaragua when it 'becomes a republic again' -- a swipe at the increasingly autocratic Ortega.
During Chamorro's seven years as president between 1990 and 1997 she helped end a civil war that raged for much of the 1980s between US-backed 'Contra' rebels and Ortega's left-wing Sandinista government.
She credited her victory with speaking to Nicaraguans in language 'typical of a homemaker and a mother.'
She moved to Costa Rica in 2023 to be close to her children, three of whom are living in exile because of their opposition to Ortega.
Ortega, 79, led Nicaragua for a decade after toppling a US-backed dictatorship in 1979.
Since returning to power in 2007, he has shown increasingly authoritarian tendencies.
He has seized control of all branches of government and shut down thousands of NGOs since major anti-government protests in 2018, which he branded a US-backed coup bid.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Star
3 hours ago
- The Star
Rice prices double in Japan as inflation accelerates
A customer purchases a bag of government stockpiled rice on sale in a section of convenience store chain Seven-Eleven Japan in Tokyo on June 17, 2025. The price of rice went up 101 per cent on-year in May. - AFP TOKYO: Rice prices doubled last month in Japan as core inflation accelerated, official data showed Friday (June 20), posing a threat to Prime Minister Shigeru Ishiba ahead of July elections. The vote for parliament's upper house, due next month, is crucial for Ishiba after public support for his government tumbled to its lowest level since he took office in October, partly due to frustration over the cost of living. In May, Japan's core inflation rate, which excludes volatile fresh food prices, hit 3.7 per cent - its highest level since January 2023 - interior ministry data showed. The figure narrowly beat market expectations and was up from a 3.5 per cent year-on-year rise logged in April. Rice was more than twice as expensive as a year previously - despite the government releasing its emergency stockpile of the staple grain to try to bring its price down. A supply chain snarl-up has caused a shortage of rice in shops, with the grain's price up 101 per cent on-year in May, compared to the eye-watering 98 per cent rise in April. The government began releasing stockpiles in February in an attempt to drive down prices, something it has only previously done during disasters. Electricity bills were 11.3 per cent higher in May, and gas fees rose 5.4 per cent, according to Friday's data. Excluding energy and fresh food, Japan's consumer price index (CPI) rose 3.3 per cent, compared to April's 3.0 per cent. To help households combat inflation, Ishiba has pledged cash handouts of 20,000 yen (US$139) for every citizen, and twice as much for children, ahead of the election. The 68-year-old leader's coalition was deprived of a majority in the powerful lower house in October as voters vented their anger at rising prices and political scandals. It was the worst election result in 15 years for the Liberal Democratic Party (LDP), which has governed Japan almost continuously since 1955. Earlier this week the Bank of Japan kept its interest rates unchanged and said it would taper its purchase of government bonds at a slower pace, as trade uncertainty threatens to weigh on the world's number four economy. "Policy flip-flops and delayed pass-through from producers to consumers mean inflation will slow only gradually in the coming months," said Stefan Angrick of Moody's Analytics. "This will keep a sustained pickup in real wages out of reach, and with it a meaningful uptick in consumption." Factors behind the rice shortages include an intensely hot and dry summer two years ago that damaged harvests nationwide. Since then some traders have been hoarding rice in a bid to boost their profits down the line, experts say. The issue was made worse by panic-buying last year prompted by a government warning about a potential "megaquake" that did not strike. Going forward, US tariffs are expected to weigh on Japan's growth, with economists predicting a slowdown ahead. Intensifying fighting between Iran and Israel was also adding pressure for energy prices to head north, posing a further risk to the Japanese economy. - AFP
New Straits Times
6 hours ago
- New Straits Times
EU bars Chinese firms from major state medical equipment contracts
BRUSSELS: The European Union on Friday banned Chinese firms from government medical device purchases worth more than five million euros (US$5.8 million) in retaliation for limits Beijing places on access to its own market. The latest salvo in trade tensions between the 27-nation bloc and China covers a wide range of healthcare supplies, from surgical masks to X-ray machines, that represent a market worth 150 billion euros in the EU. "Our aim with these measures is to level the playing field for EU businesses," the bloc's trade commissioner Maros Sefcovic said. "We remain committed to dialogue with China to resolve these issues." In response, China accused the EU of "double standards". "The EU has always boasted that it is the most open market in the world, but in reality, it has gradually moved towards protectionism", foreign ministry spokesman Guo Jiakun said at a regular press briefing. "Under the guise of fair competition (the EU) actually carries out unfair competition, which is a typical case of double standards." The European Commission said in a statement the move was in "response to China's longstanding exclusion of EU-made medical devices from Chinese government contracts." Brussels said just under 90 per cent of public procurement contracts for medical devices in China "were subject to exclusionary and discriminatory measures" against EU firms. In addition to barring Chinese firms from major state purchases, "inputs from China for successful bids" would also be limited to 50 per cent, it said. Over the last three years, Brussels and Beijing have come into conflict in a number of economic sectors, including electric cars, the rail industry, solar panels and wind turbines. The decision on medical devices comes at a time of heightened trade tensions with President Donald Trump's United States, which has imposed customs surcharges on imports from all over the world, including Europe. The EU has decided to take a tougher stance on trade in recent years, adopting a vast arsenal of legislation to better defend its businesses against unfair competition. In April 2024, the commission opened an investigation into Chinese public contracts for medical devices, the first under a new mechanism introduced by the EU in 2022 to obtain better access to overseas state purchases. China, on the other hand, accuses Europe of protectionism. After a year of negotiations, the commission, which manages trade policy on behalf of the 27 member states, said it had failed to make any progress with China. "The measure seeks to incentivise China to cease its discrimination against EU firms and EU-made medical devices and treat EU companies with the same openness as the EU does with Chinese companies and products," Brussels said.
New Straits Times
8 hours ago
- New Straits Times
EU bars Chinese firms from most medical device tenders
BRUSSELS: The European Union will bar Chinese companies from participating in EU public tenders for medical devices worth €60 billion or more (US$68.90 billion) per year after concluding that EU companies are not given fair access in China. The measure announced by the European Commission on Friday is the first under the EU's International Procurement Instrument, which entered into force in 2022 and is designed to ensure reciprocal market access. The new restrictions are likely to increase tensions with Beijing, already inflamed by EU tariffs on China-built electric vehicles, Chinese measures against EU brandy, and curbs on exports of rare earths that the EU wants resolved by an EU-China summit in July. The Commission said on Friday that it would exclude Chinese companies from EU government purchases above €5 million. An EU official said, guided by figures from Medtech Europe, the EU medical technology market was worth some €150 billion in 2023, with public procurement accounting for a 70 per cent share. Contracts of over €5 million were only four per cent of tenders, but made up some 60 per cent by value, the official said. Successful bids will have to ensure they include no more than 50 per cent of medical devices from China. If there are no alternative suppliers, the exclusion will not apply. EU members backed the plan earlier this month. The Commission has previously said it found "clear evidence" that China favoured Chinese devices for hospitals and that its tender conditions led to abnormally low bids that profit-oriented companies could not offer. A Commission official said the ban would cover medical equipment including imaging equipment, artificial body parts and medical clothing. China's commerce ministry has previously described the proposed EU measures as "protectionist", urging the EU to be fair and transparent and for both sides to resolve differences through cooperation and dialogue. The Commission said China had not proposed any corrective action to remedy the situation, but an agreement was still possible.
